Tonghua Dongbao Medicines Company Limited operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tonghua Dongbao Medicines Company Limited with three other
companies in this sector in China:
China Biologic Products, Inc.
sales of 1.86 billion Chinese Renmimbi [US$270.14 million]
of which 100%
was Human Blood Product),
Hualan Biological Engineering Inc
(1.47 billion Chinese Renmimbi [US$213.06 million]
of which 92%
was Blood Product), and
Beijing Tiantan Biologic.
(1.62 billion Chinese Renmimbi [US$234.36 million]
Tonghua Dongbao Medicines Company Limited reported sales of 1.67 billion Chinese Renmimbi (US$241.64 million)
December of 2015.
increase of 15.0%
versus 2014, when the company's sales were 1.45 billion Chinese Renmimbi.
Sales at Tonghua Dongbao Medicines Company Limited have increased during each of the previous five years
(and since 2010, sales have increased a total of 163%).
Sales of Pharmaceutical saw an increase
17.8% in 2015, from
1.38 billion Chinese Renmimbi to 1.62 billion Chinese Renmimbi.
Not all segments of Tonghua Dongbao Medicines Company Limited experienced an increase in sales in 2015:
sales of Plastic Construction Material fell 37.2% to 45.76 million Chinese Renmimbi.